Florida Expands 7-OH Ban, Intensifying Compliance Scrutiny for Kratom Merchants

Florida Expands 7-OH Ban, Intensifying Compliance Scrutiny for Kratom Merchants

Tallahassee, FL – June 24, 2026 – Florida Attorney General James Uthmeier has signed a new emergency rule, significantly broadening the state's ban on highly concentrated 7-hydroxymitragynine (7-OH) and several related compounds. This action, an expansion of a previous emergency rule, classifies these substances as Schedule I controlled substances, carrying severe penalties for non-compliance.

What Happened: The new emergency rule, effective immediately, sets stringent limits on the concentration of 7-OH and a range of other kratom-derived compounds. Specifically, no product may contain more than 1 milligram of these chemicals per gram in solids or pills, or per milliliter in liquids. Furthermore, any product containing 7-OH or its related compounds must also contain at least 100 times more mitragynine by mass, effectively prohibiting super-concentrated formulations. The banned compounds now include 7-hydroxymitragynine, mitragynine pseudoindoxyl, 7-acetoxymitragynine, 9-hydroxycorynantheidine, 10-hydroxycorynantheidine, MGM-15, and MGM-16. Violations of this rule are now subject to felony arrests and potential prison sentences of up to 30 years. Attorney General Uthmeier cited 587 overdose deaths in Florida since 2013 linked to 7-OH and related compounds as a driving factor for this expanded crackdown.

Why It Matters to Kratom Merchants and Consumers: This broadened ban has immediate and profound implications for kratom merchants and consumers in Florida. For merchants, any products containing these compounds above the new, extremely low thresholds are now illegal and must be immediately removed from shelves. This directly impacts highly concentrated kratom extracts, shots, gummies, and other liquid or solid formulations frequently found in gas stations, vape shops, and online. The state's intent is to curb the availability of highly potent and potentially addictive substances, particularly to protect children and teens.

However, as highlighted by Florida Politics, this narrow ban on 7-OH may not address the "bigger kratom problem" of a broader unregulated market for other kratom products, potentially benefiting certain industry segments while leaving other concerns unaddressed. For consumers, access to these specific high-concentration products will cease, but the regulatory landscape for traditional kratom leaf products remains distinct, though subject to ongoing legislative debate.

Compliance Implications: The most critical compliance implication is the immediate legal necessity for merchants to cease the sale of any product violating these new concentration limits. This requires a thorough review of inventory and product formulations. Manufacturers must reformulate their products to meet the stringent 1mg/gram or ml limit and the 100x mitragynine ratio, making the production of highly concentrated 7-OH products effectively unfeasible. Florida's Agriculture Commissioner Wilton Simpson has stated that inspectors will be enforcing these new rules.

What High-Risk Merchants Need to Know about COAs, Lab Testing, and Regulatory Compliance: For high-risk kratom merchants, proactive and rigorous compliance measures are no longer optional but essential for continued operation.

1. Mandatory Third-Party Lab Testing: It is paramount to engage reputable, independent third-party laboratories for comprehensive testing of all kratom products, especially extracts and concentrated forms.
2. Detailed Certificates of Analysis (COAs): COAs must explicitly detail the concentrations of all newly banned and restricted alkaloids, including 7-hydroxymitragynine, mitragynine pseudoindoxyl, 7-acetoxymitragynine, 9-hydroxycorynantheidine, 10-hydroxycorynantheidine, MGM-15, and MGM-16.
3. Verify Mitragynine Ratio: Crucially, COAs must also demonstrate that any product containing even trace amounts of 7-OH or related compounds adheres to the new requirement of having at least 100 times more mitragynine by mass.
4. Rigorous Supplier Vetting: Merchants must thoroughly vet their suppliers, demanding current and complete COAs for every batch of product. Relying on outdated or generic COAs is a significant legal liability.
5. Stay Informed: The kratom regulatory landscape is highly dynamic. Merchants must actively monitor legislative developments and emergency rules at both state and federal levels. This Florida action underscores how rapidly regulations can change and the severe consequences of non-compliance.
6. Beyond Alkaloid Limits: While this ban focuses on specific alkaloids, the broader conversation around comprehensive kratom regulation, including product labeling, purity, and age restrictions, continues. Merchants should anticipate further regulatory scrutiny and strive for transparency and best practices across all aspects of their operations.